Researchers work at a laboratory at the University of Queensland (UQ) in Brisbane, Australia. The coronavirus vaccine being developed with local biotech firm CSL will not progress to Phase 2/3 trials. Photo: Xinhua
Researchers work at a laboratory at the University of Queensland (UQ) in Brisbane, Australia. The coronavirus vaccine being developed with local biotech firm CSL will not progress to Phase 2/3 trials. Photo: Xinhua
Adam Taylor
Opinion

Opinion

Adam Taylor

Why did Australia’s University of Queensland/CSL coronavirus vaccine fail?

  • Participants in the Phase 1 trial received ‘false positive’ HIV tests because its ’molecular clamp’ technology was formulated with parts of HIV protein
  • There were fears people would believe they had HIV when they did not, undermining confidence in the Covid-19 vaccine programme

Researchers work at a laboratory at the University of Queensland (UQ) in Brisbane, Australia. The coronavirus vaccine being developed with local biotech firm CSL will not progress to Phase 2/3 trials. Photo: Xinhua
Researchers work at a laboratory at the University of Queensland (UQ) in Brisbane, Australia. The coronavirus vaccine being developed with local biotech firm CSL will not progress to Phase 2/3 trials. Photo: Xinhua
READ FULL ARTICLE